Lion Biotechnologies, Inc. To Present At The 4th Annual Cancer Immunotherapy Conference
3/24/2014 8:58:50 AM
LOS ANGELES, March 24, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), today announced that Chief Executive Officer Manish Singh, Ph.D., will be presenting at the 4th Annual Cancer Immunotherapy Conference at the New York Academy of Medicine in New York City. The presentation is scheduled for Thursday, March 27, 2014, at 9:00 am Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
comments powered by